StockNews.com Begins Coverage on Aspira Women’s Health (NASDAQ:AWH)

StockNews.com began coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a research note issued to investors on Monday. The brokerage issued a hold rating on the stock.

Aspira Women’s Health Stock Up 4.2 %

Shares of AWH stock opened at $0.75 on Monday. The company has a 50 day moving average price of $0.79 and a 200-day moving average price of $0.97. Aspira Women’s Health has a 52 week low of $0.67 and a 52 week high of $5.65. The firm has a market capitalization of $12.50 million, a PE ratio of -0.62 and a beta of 1.42.

Institutional Investors Weigh In On Aspira Women’s Health

A hedge fund recently bought a new stake in Aspira Women’s Health stock. Pine Valley Investments Ltd Liability Co purchased a new position in Aspira Women’s Health Inc. (NASDAQ:AWH) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 31,200 shares of the company’s stock, valued at approximately $25,000. Pine Valley Investments Ltd Liability Co owned approximately 0.19% of Aspira Women’s Health as of its most recent filing with the Securities and Exchange Commission. 12.19% of the stock is currently owned by institutional investors.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.